- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01583010
Improvement of Needle Visibility in Ultrasound Guided Regional Anaesthesia
Improvement of Needle Visibility in In-line Regional Anaesthesia by "Advanced Needle Visualization Technology ®"
Needle tip visualization, although fundamental to the safety and efficacy of ultrasound-guided regional anesthesia (UGRA), can be extremely challenging. This problem is most marked at steep insertion angles. Studies in patients with UGRA demonstrate that echogenic needle designs have the potential to offer improved visibility and accuracy.
Our study pursues another approach. We use (for differentiation) echogenic nerve block needles with ANV®, a new SonoSite software-upgrade (Advanced Needle Visualization Technology®). We will compare UGRA with ANV® against standard UGRA without using this SonoSite software-upgrade. Patients undergoing femoral, supraclavicular or other nerve blocks as part of their routine anesthetic management are included.
This work represents the first randomized controlled double blinded clinical trial of ANV® in patients undergoing UGRA. We hypothesize, that we can decrease the time without needle visualization (Loss of needle time in percentage of procedure time) during in-line regional anaesthesia. Furthermore we will record quality of visibility, duration of procedure and insertion angle of the needle.
Study Overview
Detailed Description
Patients scheduled to undergo surgery with femoral (n = 50) and supraclavicular (n=50) anaesthesia (100 blocks total) gets included in this study. These 50 patients will be randomized equally using sealed opaque envelopes to two parallel groups: standard treatment UGRA (n=25) and SonoSites ANV® (n= 25) UGRA.
An experienced anaesthesiologist from department of anaesthesiology, general intensive care and pain medicine will perform UGRA. Because of safety reasons and best assessment of needle visibility all UGRA in this study are going to performed with in-plane ultrasound technique. Needle length and gauge are standardized.
The ultrasound imaging of each nerve block gets recorded onto a DVD for analysis. Recording of performed UGRA will start with placement of ultrasound probe and will finish with needle leaving the skin (procedure time), get stored, checked to exclude technical failures and analysed with a one second discrimination by two blinded observers for needle visibility. All information indicating ANV®-status on ultrasound image will be deleted. Hence for procedure and following analysis we will ensure that patient and the objective observer are blinded.
Images with full needle visibility will be related to images without needle visibility. Time of needle visibility will be described in percent of procedure time.
Enduring visualization of complete needle in ultrasound beam won't be given during the whole procedure. For differentiation of complete needle visibility, partial or no visibility in in-plane UGRA, we will use needles with ultrasound visible marks (echogenic needles). If the objective observers will visualize all 3 marks and pole of the needle in ultrasound-image, needle is completely in-plane and visible for analysis. For partial visibility of marks we will use a needle visibility grading dependent to number of visible marks (One mark = poor visibility, two marks = middle visibility, three marks=good visibility). If there won't be visible marks in ultrasound image, needle is in absence and gets evaluated as "not visible".
Dependent to position of anatomic target structure each nerve block will need a different angle of needle insertion. This measured angle will be used to compare times of needle visibility dependent to insertion angle of the needle. Significant differences may appear especially in steep angles of needle.
In this study we will use Naropin® (Ropivaciane, 7.5mg/ml) as local anaesthetic for all UGRA.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Reinhard Hahn, Univ. Lektor Dr.
- Phone Number: +431404004100
- Email: reinhard.hahn@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria, 1090
- Recruiting
- Department of Anesthesia, Intensive Care Medicine and Pain Therapy, Medical University Vienna
-
Contact:
- Reinhard Hahn, Univ. Lektor Dr.
- Phone Number: +431404004100
- Email: reinhard.hahn@meduniwien.ac.at
-
Contact:
- Kettner Stephan, Prof. Dr.
- Phone Number: +431404004100
- Email: stephan.kettner@meduniwien.ac.at
-
Principal Investigator:
- Reinhard Hahn, Univ. Lektor Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients, who give consent and undergo a femoral or supraclavicular nerve block.
Exclusion Criteria:
- Patients get excluded if they refused or are unable to give consent by other reasons
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard Treatment Group
Patients receiving ultrasound guided regional anaesthesia without using Advanced Needle Visualization Technology(R)
|
|
Active Comparator: ANV ® Group
Patients receiving ultrasound guided regional anaesthesia with using Advanced Needle Visualization Technology(R)
|
Device: Advanced Needle Visualization Technology ® Software update for SonoSites M-Turbo® and S-series™ ultrasound systems with enhanced 15-20Mhz ultrasound probe. Arms: ANV ® Group
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time of needle visibilty in ultrasound-image
Time Frame: At time of ultrasound guided regional anaesthesia
|
Measure is given in percentage of procedure time
|
At time of ultrasound guided regional anaesthesia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedure time
Time Frame: At time of ultrasound guided regional anaesthesia
|
Duration of placement of the ultrasound probe up to needle-removal out of the skin.
|
At time of ultrasound guided regional anaesthesia
|
Angle of needle insertion
Time Frame: At time of ultrasound guided regional anaesthesia
|
Measurement of puncture-angle between skin an needle in the ultrasound-image.
|
At time of ultrasound guided regional anaesthesia
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Reinhard Hahn, Univ. Lektor Dr., Medical University of Vienna
Publications and helpful links
General Publications
- Chin KJ, Perlas A, Chan VW, Brull R. Needle visualization in ultrasound-guided regional anesthesia: challenges and solutions. Reg Anesth Pain Med. 2008 Nov-Dec;33(6):532-44. doi: 10.1016/j.rapm.2008.06.002.
- Hebard S, Hocking G. Echogenic technology can improve needle visibility during ultrasound-guided regional anesthesia. Reg Anesth Pain Med. 2011 Mar-Apr;36(2):185-9. doi: 10.1097/aap.0b013e31820d4349.
- Maecken T, Zenz M, Grau T. Ultrasound characteristics of needles for regional anesthesia. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):440-7. doi: 10.1016/j.rapm.2007.07.002.
- Chapman GA, Johnson D, Bodenham AR. Visualisation of needle position using ultrasonography. Anaesthesia. 2006 Feb;61(2):148-58. doi: 10.1111/j.1365-2044.2005.04475.x.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EK572/2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anaesthesia
-
Centre Hospitalier Universitaire DijonCompletedOpioid Free Anaesthesia | Opioid AnaesthesiaFrance
-
Centre Hospitalier Universitaire DijonCompletedOpioid Free Anaesthesia | Opioid AnaesthesiaFrance
-
B. Braun Melsungen AGTigermed Consulting Co., Ltd; B. Braun Medical International Trading Company...CompletedGeneral Anaesthesia | Induction of AnaesthesiaChina
-
Algemeen Stedelijk ZiekenhuisNot yet recruitingPostoperative Opioid-Sparing Effect of a Pecto-Intercostal Fascial Block and Opioid-Free Anesthesia.Opioid Free Anaesthesia | Opioid Anaesthesia
-
Dokuz Eylul UniversityCompleted
-
Cork University HospitalCompleted
-
Glostrup University Hospital, CopenhagenCompleted
-
King Faisal UniversityCompleted
-
Tampere University HospitalCompleted
Clinical Trials on ANV(R)
-
University of California, Los AngelesUniversity of Colorado, Denver; National Institute of Allergy and Infectious... and other collaboratorsCompletedRNA Virus Infections | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Respiratory Tract Disease | Virus Disease | Physiological Effects of Drugs | VaccinesUnited States
-
Klinikum NürnbergUnknown
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)CompletedRespiratory Tract Infections | Influenza | VaccinesUnited States
-
LifeScanCompleted
-
Daping Hospital and the Research Institute of Surgery...Not yet recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedHealthy VolunteersFrance
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)CompletedImmunization RatesUnited States
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)Completed